Floatz logo

ANTI-HB-EGF MONOCLONAL ANTIBODY KHK2866

Primary Peritoneal Neoplasm

Kyowa Kirin Co., Ltd.monoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

154 Active assets in the Primary Peritoneal Neoplasm cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
GOG Foundation
Phase 3BBB
Carboplatin
University of Washington
Phase 3BBB
Inno-206
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3BBB
Hycamtin
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3BBB
PEGFILGRASTIM
TORL Biotherapeutics, LLC
Phase 2/3BBB

View all 50 →

Same molecule, other indications

ANTI-HB-EGF MONOCLONAL ANTIBODY KHK2866 is also rated in:

fallopian tube neoplasmDormant
CC
Indicative ·
41 / 100
View asset →
ovarian neoplasmDormant
C
Indicative ·
39 / 100
View asset →
neoplasmDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →